Kiora Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Kiora Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(9.99%),Lincoln Park Capital, LLC(9.99%), etc.
Kiora Pharmaceuticals | D: Filing D
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals
Kiora Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(9.9%),Orin H(9.9%)
Kiora Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(1.5%),Daniel B. Asher(1.5%), etc.
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals: Q3 2023 Earnings Report
Kiora Pharmaceuticals | 8-K: Current report
Kiora Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Tosca Melissa
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Daniels Eric Joseph
Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Strem Brian M.
No Data